NCT07309770 2025-12-30Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard TherapiesFudan UniversityPhase 2 Recruiting90 enrolled
NCT06683846 2025-08-24Ivonescimab in the Treatment of Multiple Advanced TumorsFudan UniversityPhase 2 Recruiting400 enrolled